— Modified FOLFIRINOX failed to improve disease-free survival in stage III disease Intensified adjuvant chemotherapy did not improve disease-free survival (DFS) compared with standard chemotherapy in patients with high-risk stage III colon cancer, the phase III IROCAS trial showed. While overall…
DEAR DR. ROACH: Iâm an 85-year-old woman. I took the Cologuard test a month ago, and it came back positive. My gastrointestinal doctor said that at my age, he wouldnât perform a colonoscopy. I asked for other alternatives,…
Boston-based researchers announced Wednesday the discovery of new biological clues about why colorectal cancer can behave more aggressively in young patients. The findings are based on the analysis of 189 tumors from patients, including 54 who were diagnosed with the cancer before…
Longwood Construction Notice: Ongoing construction near our Longwood campus may affect traffic in the area. Check the latest access changes before you travel. Learn about Dana-Farber’s expert cancer care and the innovative treatment options we offer for adults and children.
Dana-Farber Cancer Institute researchers, along with Mass General Brigham researchers from the Gene Lay Institute of Immunology and Inflammation, and the Broad Institute, have uncovered biological clues to why colorectal cancer can behave more aggressively in younger people. New study…
It's not just younger groups with rising colorectal cancer rates − older age groups are seeing increases too, according to a new study, In the study, published on Oct. 27 in NEJM Evidence, researchers found rates are rising across all age groups…
National Gastric Cancer Awareness Month campaign brings patient and caregiver experiences into the spotlight, from delayed diagnoses and treatment advances to survivorship, loss and hope Unlike some other cancers, stomach cancer has no routine screening program. And symptoms can resemble…
Ashley Y. Son, Heather Selby, Todd Wagner, Vipul Sheth, Erqi Pollom, Arden M. Morris The Stanford University Department of Surgery is dedicated to inventing the future of surgical care through: • pioneering cutting-edge research, • developing the next generation of leaders, and • healing through…
Yewon A Son, Heather M. Selby, Vipul R. Sheth, Todd Wagner, Erqi L. Pollom, Arden M. Morris The Stanford University Department of Surgery is dedicated to inventing the future of surgical care through: • pioneering cutting-edge research, • developing the next generation of leaders, and • healing…
PALO ALTO, Calif., October 29, 2026--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, applauded the enactment of a new law (HB 1123) in Pennsylvania aligning insurance coverage for colorectal cancer screening to reflect the latest American Cancer Society (ACS) and…
Colon and rectal cancer: symptoms, diagnosis, treatment, the rise in younger adults and research.
An article joins this feed when it matches these terms. Each one is also a search of its own.